Gene · 9448
Papers1,615
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,615
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MAP4K4 exacerbates cardiac microvascular injury in diabetes by facilitating S-nitrosylation modification of Drp1. | Cardiovasc Diabetol | 2024 | 38724987 | PubTator, text mining | PubMed |
| Syndromic craniosynostosis caused by a novel missense variant in MAP4K4: Expanding the genotype-phenotype relationship in RASopathies. | Clin Genet | 2024 | 38679877 | PubTator, text mining | PubMed |
| Blockade of a novel MAP4K4-LATS2-SASH1-YAP1 cascade inhibits tumorigenesis and metastasis in luminal breast cancer. | J Biol Chem | 2024 | 38657867 | PubTator, text mining | PubMed |
| FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner. | Med Oncol | 2024 | 38643333 | PubTator, text mining | PubMed |
| Peptide Transporter 1-Mediated Dipeptide Transport Promotes Hepatocellular Carcinoma Metastasis by Activating MAP4K4/G3BP2 Signaling Axis. | Adv Sci (Weinh) | 2024 | 38639383 | PubTator, text mining | PubMed |
| Exploration of Diagnostic Markers Associated with Inflammation in Chronic Kidney Disease Based on WGCNA and Machine Learning. | Crit Rev Immunol | 2024 | 38618725 | PubTator, text mining | PubMed |
| Overcoming radioresistance of breast cancer cells with MAP4K4 inhibitors. | Sci Rep | 2024 | 38548749 | PubTator, text mining | PubMed |
| A Compact Reprogrammed Genetic Code for De Novo Discovery of Proteolytically Stable Thiopeptides. | J Am Chem Soc | 2024 | 38491946 | PubTator, text mining | PubMed |
| TNIK depletion induces inflammation and apoptosis in injured renal proximal tubule epithelial cells. | Am J Physiol Renal Physiol | 2024 | 38482555 | PubTator, text mining | PubMed |
| Considerations on the implementation of MAP4K4 inhibitors as cancer treatment. | Expert Opin Ther Targets | 2024 | 38421000 | PubTator, text mining | PubMed |
| MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGFβ2-Smad2/3 signaling pathway in cervical cancer. | Mol Oncol | 2024 | 38383842 | PubTator, text mining | PubMed |
| Regulation of AMPK activation by extracellular matrix stiffness in pancreatic cancer. | Genes Dis | 2024 | 38292173 | PubTator, text mining | PubMed |
| Exploring the Mechanism of Immediate Analgesia Induced by Tuina Intervention on Minor Chronic Constriction Injury in Rats Using LC-MS. | J Pain Res | 2024 | 38283563 | PubTator, text mining | PubMed |
| Inflammation and Starvation Affect Housekeeping Gene Stability in Adipose Mesenchymal Stromal Cells. | Curr Issues Mol Biol | 2024 | 38275668 | PubTator, text mining | PubMed |
| CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review. | Biomedicines | 2024 | 38275409 | PubTator, text mining | PubMed |
| Dichotomous role of the serine/threonine kinase MAP4K4 in pancreatic ductal adenocarcinoma onset and metastasis through control of AKT and ERK pathways. | J Pathol | 2024 | 38229581 | PubTator, text mining | PubMed |
| Kinase inhibitor pulldown assay (KiP) for clinical proteomics. | Clin Proteomics | 2024 | 38225548 | PubTator, text mining | PubMed |
| Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease. | Cell Death Dis | 2024 | 38177100 | PubTator, text mining | PubMed |
| The characteristics of elderly suicidal attempters in the emergency department in Korea: a retrospective study. | J Yeungnam Med Sci | 2024 | 38155553 | PubTator, text mining | PubMed |
| Analyzing the ER stress response in ALS patient derived motor neurons identifies druggable neuroprotective targets. | Front Cell Neurosci | 2023 | 38314348 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9448/papers?page=5